Breedlove Robert Charles 4
4 · Phathom Pharmaceuticals, Inc. · Filed Nov 5, 2025
Insider Transaction Report
Form 4
Breedlove Robert Charles
Principal Accounting Officer
Transactions
- Sale
Common Stock
2025-11-03$13.51/sh−524$7,079→ 47,407 total
Holdings
- 6,945.4(indirect: By 401(k))
Common Stock
Footnotes (1)
- [F1]Represents shares sold to satisfy tax withholding obligations upon the settlement of restricted stock units.